1. Singapore Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Jiutian Chemical Group Limited

Jiutian Chemical Group Limited

C8R.SI
Jiutian Chemical Group LimitedSG flagStock Exchange of Singapore
0.02
SGD
-NaN
- -
41.76MMarket Cap
Jiutian Chemical Group Limited
C8R.SI
(Stock Exchange of Singapore)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.28
0.5
0.55
0.54
0.52
0.37
0.39
0.62
0.72
0.58
0.62
1.09
1.22
0.3
0.03
- -
0.82
Revenue per Share
-0.09
-0.05
- -
0.01
0.01
- -
- -
0.04
0.01
-0.14
0.09
0.16
0.25
-0.17
-0.07
- -
0.16
Basic EPS, GAAP
0.04
0.09
-0.15
0.03
0.11
-0.04
-0.02
0.04
0.01
0.03
0.07
0.32
0.21
-0.26
-0.09
- -
0.14
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.02
0.04
0.06
- -
- -
- -
Dividend per Share
0.26
0.2
0.22
-0.12
-0.11
-0.11
0.25
0.29
0.3
0.17
0.28
0.39
0.56
0.33
0.26
- -
0.33
Book Value per Share
0.27
0.21
0.21
0.24
0.27
0.26
0.26
0.3
0.32
0.16
0.28
0.41
0.61
0.38
0.31
- -
0.34
Tangible Book Value per Share
1,655
1,655
1,655
1,795
1,818
1,818
1,818
1,818
1,818
1,818
1,849
1,988
1,988
1,988
1,988
- -
1,903
Basic Weighted Avg Shares
462
830
918
971
937
678
709
1,124
1,308
1,054
1,146
2,173
2,435
599
51
110
1,558
Sales/Revenue/Turnover
-19.04
-9.06
-0.64
1.62
2.32
-3.29
0.3
9.05
6.56
2.71
21.01
28.38
26.52
-51.66
-223.82
-123.04
26.95
Operating Margin (%)
34
29
28
28
31
29
30
31
29
28
26
29
22
23
25
37
29
Depreciation Expense
-155
-91
1
21
27
-9
1
71
22
-248
174
325
490
-345
-148
-240
299
Net Income, GAAP
- -
- -
1.6
- -
3.03
- -
- -
22.5
40.5
- -
28.59
33.12
27.03
- -
- -
- -
28.14
Effective Tax Rate (%)
-33.59
-10.94
0.14
2.19
2.88
-1.29
0.08
6.3
1.69
-23.56
15.15
14.95
20.14
-57.58
-292.47
-218.42
19.17
Profit Margin (%)
-213
-269
-258
-212
-151
-116
-145
-113
-21
10
251
578
992
466
299
135
392
Working Capital
- -
- -
- -
- -
- -
50
50
- -
- -
- -
- -
50
50
66
101
50
- -
LT Debt
456
364
366
439
493
485
485
555
580
301
523
814
1,221
766
618
378
650
Total Equity
- -
- -
-1.61
3.95
4.5
- -
- -
11.61
6.19
- -
20.92
39.62
35.96
- -
- -
- -
35.13
Return on Invested Capital (%)
- -
- -
0.38
29.61
-14.16
- -
- -
11.17
3.23
- -
22.32
35.48
43.98
- -
- -
- -
37.31
Return on Capital (%)
-30.33
-23.64
0.38
- -
- -
- -
- -
14.36
4.09
-58.25
42.71
50.8
52.19
-39.01
-25.45
-61.85
62.32
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'20
Mar'21
Jun'21
ST Debt
344
338
248
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,988
1,988
1,988
Market Capitalization
736
758
767

Working Capital

FRC

•

in mil. unless spec.
Dec'20
Mar'21
Jun'21
Total Current Assets
1,158
1,086
1,275
Cash, Cash Equivalents & STI
260
368
244
Accounts Receivable, Net
53
679
806
Inventories
39
39
36
Total Current Liabilities
907
739
883
Payables & Accruals
- -
- -
- -
ST Debt
344
338
248
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.48%
2.06%
-38.78%
Free Cash Flow
5.88%
16.52%
-13.7%
Net Income, GAAP
1,038.69%
-5.46%
62.02%
Sales/Revenue/Turnover
12.05%
10.32%
116.96%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
232
162
- -
- -
599
2024
- -
- -
- -
- -
51
2025
- -
- -
- -
- -
110

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.06
- -
- -
- -
-0.17
2024
- -
- -
- -
- -
-0.07
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.06
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Ishan Dyes and Chemicals Ltd. (ISHANCH.NS)
Braskem S.A. (BRKM6.SA)
Puyang Huicheng Electronic Material Co., Ltd. (300481.SZ)
Jiangsu ChengXing Phosph-Chemicals Co., Ltd. (600078.SS)
OCI Company Ltd. (456040.KS)
Shanghai Chlor-Alkali Chemical Co., Ltd. (600618.SS)
Business
Jiutian Chemical Group Limited, incorporated in Singapore in 2004 and listed on the SGX Catalist (C8R), is an investment holding company that manufactures and sells fine chemical products primarily in the People's Republic of China, with operations based predominantly in Henan province and sales extending to surrounding regions including Hebei, Shaanxi, Shanxi, Hubei, Shandong, Jiangsu, Anhui, and the Yangtze Delta area of Jiangsu and Zhejiang. The Group produces dimethylformamide (DMF) as its main product with an annual capacity of 150,000 tons through its wholly-owned subsidiary Anyang Jiutian Fine Chemical Co., Ltd.; methylamine as a secondary product and key feedstock for DMF with capacity supporting up to 250,000 tons; and, through its 49%-owned associate Anyang Jiulong Chemical Co., Ltd. (jointly held with Henan Energy and Chemical Industry Group Co., Ltd.), dimethylacetamide (DMAC), industrial steam, and electricity. It also engages in the processing and sale of consumable carbon dioxide and oxygen-18 and deuterium-depleted water, serving industries such as polyurethane production, pharmaceuticals, agrochemicals, electronics, acrylic fibres, petrochemicals, synthetic resins, leather-making, and food preservation; the Group's headquarters is located at 350 Orchard Road, #21-03 Shaw House, Singapore. Recent developments include the pursuit of business diversification through a proposed Synthetic Ammonia Project and Urea Production Facility lease, with a second extension of the long-stop date announced in March 2025 and ongoing efforts to secure financing, approvals, and construction preparatory work by Anyang Jiutian; multiple board reconstitutions and appointments of new non-executive independent directors including Messrs. Wang Zilong, Wang Hongli, Wong Gang, and Lim Kian Thong in April 2024 alongside retirements of prior directors; a strategic restructuring announcement involving controlling shareholders in September 2025; changes in company secretaries including a resignation in June 2024 and a new appointment in March 2025; and the commencement of members' voluntary winding-up processes for certain associated and dormant subsidiaries in 2024.